Drug Shortage Report for MOZOBIL

Last updated on 2020-11-25 History
Report ID 125088
Drug Identification Number 02377225
Brand name MOZOBIL
Common or Proper name Mozobil
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) PLERIXAFOR
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 x 2.0ml
ATC code L03AX
ATC description IMMUNOSTIMULANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2020-12-04
Actual start date
Estimated end date Unknown
Actual end date 2020-11-25
Shortage status Avoided shortage
Updated date 2020-11-25
Company comments production/ supply delay - Considering the exceptional circumstances, the remaining stock will be distributed on allocation with a limit of 2 vials per order. Pharmacies are invited to communicate with their preferred distributor to obtain more information on product availability.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v27 2020-11-25 French Compare
v26 2020-11-25 English Compare
v25 2020-11-10 French Compare
v24 2020-11-10 English Compare
v23 2020-10-23 French Compare
v22 2020-10-23 English Compare
v21 2020-10-23 French Compare
v20 2020-10-23 English Compare
v19 2020-10-23 English Compare
v18 2020-10-07 French Compare
v17 2020-10-07 English Compare
v16 2020-09-26 English Compare
v15 2020-09-25 French Compare
v14 2020-09-25 English Compare
v13 2020-09-25 English Compare
v12 2020-09-25 French Compare
v11 2020-09-25 English Compare
v10 2020-09-25 English Compare
v9 2020-09-25 French Compare
v8 2020-09-25 French Compare

Showing 1 to 20 of 27